Acquired hemophilia A: Updated review of evidence and treatment guidance.

Volume: 92, Issue: 7, Pages: 695 - 705
Published: Jun 5, 2017
Abstract
Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors) against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe. AHA tends to occur in elderly patients with comorbidities and is associated with high mortality risk from underlying comorbidities, bleeding, or treatment complications. Treatment, which consists of hemostatic management and eradication of the inhibitors,...
Paper Details
Title
Acquired hemophilia A: Updated review of evidence and treatment guidance.
Published Date
Jun 5, 2017
Volume
92
Issue
7
Pages
695 - 705
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.